1. Abbottsmith CW, Topol EJ, George BS et al (1990) Fate of patients with acute myocardial infarction with patency of the infarct-related artery achieved with successful thrombolysis versus rescue angioplasty. J Am Coll Cardiol 16:770–778
2. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS, for the DANAMI-2 Investigators (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349:733–742
3. Antman EM (1994) Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial. Circulation 90:1624–1630
4. Antman EM, Giugliano RP, Gibson CM et al (1999) Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI-14 Investigators. Circulation 99:2720–2732
5. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Gullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines www.acc.org/clinical/guidelines/stemi/index.pdf